Kidney transplant recipients with type 2 diabetes treated with a new class of anti-obesity drugs were less likely to experience organ failure and survived longer, a new study shows. Not only is obesity a known risk factor for diabetes, but it also increases risk of postsurgical complications, such as inflammation, organ rejection, and early death.
from Medical Xpress - latest medical and health news stories https://ift.tt/hDjZ5fm
